73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study confirms effectiveness of newer arthritis meds

Study confirms effectiveness of newer arthritis meds

by Amy NortonNewer oral medications for rheumatoid arthritis (RA) do work quite well in the "real world," despite some doubts that they would, according to a new study.The study, of 622 adul

Study confirms effectiveness of newer arthritis meds

by Amy NortonNewer oral medications for rheumatoid arthritis (RA) do work quite well in the "real world," despite some doubts that they would, according to a new study.The study, of 622 adul
From eye drops to potential leukaemia treatment

From eye drops to potential leukaemia treatment

by Wellcome Trust Sanger InstituteA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaAn active ingredient

From eye drops to potential leukaemia treatment

by Wellcome Trust Sanger InstituteA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaAn active ingredient
Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

byUTSouthwestern Medical CenterThis illustration depicts a nanoparticle (purple) activating the stimulator of interferon genes (STING) proteins (yellow) in dendritic cells to recruit cytot

Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

byUTSouthwestern Medical CenterThis illustration depicts a nanoparticle (purple) activating the stimulator of interferon genes (STING) proteins (yellow) in dendritic cells to recruit cytot
New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit

New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit
Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise
Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is
Genetic variation explains racial disparity in esophageal cancer cases

Genetic variation explains racial disparity in esophageal cancer cases

by University of California - San DiegoCredit: Pradipta Ghosh et al,JCI Insight(2022). DOI: 10.1172/jci.insight.161334Esophageal adenocarcinoma (EAC) is a type of cancer affecting the

Genetic variation explains racial disparity in esophageal cancer cases

by University of California - San DiegoCredit: Pradipta Ghosh et al,JCI Insight(2022). DOI: 10.1172/jci.insight.161334Esophageal adenocarcinoma (EAC) is a type of cancer affecting the
Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

by Ohio State University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Data from a national clinic

Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

by Ohio State University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Data from a national clinic
New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp
Researchers edge closer to delivering personalized medicine to cancer patients

Researchers edge closer to delivering personalized medicine to cancer patients

FEBRUARY 14, 2024byPurdue UniversityDr. Michael Childress (right), Professor of Comparative Oncology at the Purdue University College of Veterinary Medicine, is pictured with Kody (middle) and h

Researchers edge closer to delivering personalized medicine to cancer patients

FEBRUARY 14, 2024byPurdue UniversityDr. Michael Childress (right), Professor of Comparative Oncology at the Purdue University College of Veterinary Medicine, is pictured with Kody (middle) and h
Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% w

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% w
The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc